, a leader in the field of regenerative medication, announced today that it’s been issued a patent on its single-blastomere technique. The single-blastomere technology runs on the one-cell biopsy approach comparable to pre-implantation genetic medical diagnosis , which is widely used in the in vitro fertilization process and does not interfere with the embryo’s developmental potential.D., chief scientific officer of Work, said, This patent issuance represents recognition of the invention underlying our single-blastomere technology. Furthermore, this IP safety comes after on the issuance of a wide patent associated with ACT’s production and therapeutic use of Retinal Pigment Epithelial cells in 2010 2010. We are eagerly anticipating the beginning of both Phase 1/2 clinical trials in the first half of the year.Health professionals still aren’t sure how humans are being infected. The new coronavirus, which can cause severe kidney and pneumonia failure, is most closely related to a bat virus and scientists are thinking about whether bats or other pets like goats or camels are a possible source of infection. Mysterious coronavirus from Middle East promises another victimCDC wants U.S. Docs to consider mystical coronavirus from Middle EastMysterious SARS-like coronavirus may have spread human-to-humanIn Saudi Arabia last year, four members of the same family fell ill and two died. The Saudi authorities is conducting a continuing investigation into the outbreak. The seven individuals who contracted the virus are not from the same family and there is no indication that any of them were in contact with animals or had traveled recently.